---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-010713"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2025-03-27T23:59:59+00:00"
generated_at: "2026-05-24T03:36:48.629181+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Strata Q4 rev +10% to $9.6M; net loss $4.5M; adj. EBITDA improves to $2.2M in 2024

## Summary
- Q4 2024 revenue $9.6M, up 10% from $8.7M; net loss $4.5M (EPS -$1.18 vs -$1.09).
- Full-year 2024 revenue $33.6M (flat); net loss $10.1M (EPS -$2.65).
- Gross margin improved to 60.1% in Q4 (480 bps YoY); non-GAAP adj. EBITDA $2.2M vs $1.0M.
- Domestic XTRAC units reduced to 864; avg rev per device up 6% to $5,906.
- International Q4 sales $4.1M (+41% YoY); cash $8.6M at year end.

## SEC filing metadata
- accession: 0001140361-25-010713
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2025-03-27T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036125010713/0001140361-25-010713-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036125010713/ef20046329_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-010713
- JSON: https://secwatch.observer/filing/0001140361-25-010713.json
- Plain text: https://secwatch.observer/filing/0001140361-25-010713.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.